154
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Dose–response association between maternal body mass index and small for gestational age: a meta-analysis

Pages 213-218 | Received 27 Jan 2016, Accepted 20 Mar 2016, Published online: 02 Jun 2016

References

  • Tsai LY, Chen YL, Tsou KI, Mu SC. Taiwan Premature Infant Developmental Collaborative Study Group. The impact of small for gestational age on neonatal outcome among very low birth weight infants. Pediatr Neonatol 2015;56:101–7.
  • Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large-for-gestational-age infants. J Mater Fetal Neonatal Med 2014;28:1679–86.
  • Voigt M, Rochow N, Jährig K, et al. Dependence of neonatal small and large for gestational age rates on maternal height and weight-an analysis of the German Perinatal Survey. J Perinat Med 2010;38:425–30.
  • Mavalankar DV, Trivedi CC, Gray RH. Maternal weight, height and risk of poor pregnancy outcome in Ahmedabad, India. Indian Pediatr 1994;31:1205–12.
  • Mavalankar DV, Gray RH, Trivedi CR, Parikh VC. Risk factors for small for gestational age births in Ahmedabad, India. J Trop Pediatr 1994;40:285–90.
  • Hamling J, Lee P, Weitkunat R, Ambühl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954–70.
  • Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp/ [last accessed 27 Jan 2016].
  • Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40–57.
  • The Organisation for Economic Co-operation and Development. DAC list of ODA recipients: effective for reporting on 2014, 2015 and 2016 flows. Available from: http://www.oecd.org/dac/stats/documentupload/DAC%20List%20of%20ODA%20Recipients%202014%20final.pdf/ [last accessed 27 Jan 2016].
  • Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66–73.
  • Anderson NH, Sadler LC, Stewart AW, et al. Independent risk factors for infants who are small for gestational age by customised birthweight centiles in a multi-ethnic New Zealand population. Aust N Z J Obstet Gynaecol 2013;53:136–42.
  • Rodrigues T, Barros H. Comparison of risk factors for small-for-gestational-age and preterm in a Portuguese cohort of newborns. Matern Child Health J 2007;11:417–24.
  • Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol 1998;105:1011–17.
  • Goetzinger KR, Cahill AG, Macones GA, Odibo AO. The relationship between maternal body mass index and tobacco use on small-for-gestational-age infants. Am J Perinatol 2012;29:153–8.
  • Harita N, Kariya M, Hayashi T, et al. Gestational bodyweight gain among underweight Japanese women related to small-for-gestational-age birth. J Obstet Gynaecol Res 2012;38:1137–44.
  • Khashan AS, Kenny LC. The effects of maternal body mass index on pregnancy outcome. Eur J Epidemiol 2009;24:697–705.
  • Ota E, Haruna M, Suzuki M, et al. Maternal body mass index and gestational weight gain and their association with perinatal outcomes in Viet Nam. Bull World Health Organ 2011;89:127–36.
  • Tanaka T, Ashihara K, Nakamura M, et al. Associations between the pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in Japanese women. J Obstet Gynaecol Res 2014;40:1296–303.
  • Tsukamoto H, Fukuoka H, Inoue K, et al. Restricting weight gain during pregnancy in Japan: a controversial factor in reducing perinatal complications. Eur J Obstet Gynecol Reprod Biol 2007;133:53–9.
  • Tsukamoto H, Fukuoka H, Koyasu M, et al. Risk factors for small for gestational age. Pediatr Int 2007;49:985–90.
  • Watanabe H, Inoue K, Doi M, et al. Risk factors for term small for gestational age infants in women with low prepregnancy body mass index. J Obstet Gynaecol Res 2010;36:506–12.
  • Rasmussen KM, Yaktine AL, eds. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: The National Academic Press; 2009.
  • Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn. J Perinat Med 2009;37:623–35.
  • Mazaki-Tovi S, Romero R, Kim SK, et al. Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med 2010;23:857–68.
  • Mazaki-Tovi S, Kasher-Meron M, Hemi R, et al. Chemerin is present in human cord blood and is positively correlated with birthweight. Am J Obstet Gynecol 2012;207:412.e1–10.
  • Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008;21:279–87.
  • Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23.
  • López-Jaramillo P, Gómez-Arbeláez D, López-López J, et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig 2014;18:37–45.
  • Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000;71:1344S–52S.
  • Egger M, Smith GD, Altman DG, eds. Systematic reviews in healthcare: meta-analysis in context. London: BMJ; 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.